Qingdao Vland Biotech Co Ltd (603739) - Total Liabilities

Latest as of September 2025: CN¥1.14 Billion CNY ≈ $166.87 Million USD

Based on the latest financial reports, Qingdao Vland Biotech Co Ltd (603739) has total liabilities worth CN¥1.14 Billion CNY (≈ $166.87 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how efficiently does Qingdao Vland Biotech Co Ltd generate cash to assess how effectively this company generates cash.

Qingdao Vland Biotech Co Ltd - Total Liabilities Trend (2014–2024)

This chart illustrates how Qingdao Vland Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 603739 asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Qingdao Vland Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Qingdao Vland Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Blue Moon Zinc Corp V:MOON	Canada	CA$26.66 Million
Zhengzhou Coal Mining Machinery Group Company Limited F:ZGC	Germany	€26.61 Billion
ENCE Energía y Celulosa S.A MC:ENC	Spain	€1.07 Billion
Raydium Semi-Conductor TW:3592	Taiwan	NT$7.71 Billion
Quantum eMotion Corp. V:QNC	Canada	CA$555.19K
Sariguna Primatirta PT JK:CLEO	Indonesia	Rp766.51 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Qingdao Vland Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Qingdao Vland Biotech Co Ltd.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.08	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.37	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Qingdao Vland Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Qingdao Vland Biotech Co Ltd (2014–2024)

The table below shows the annual total liabilities of Qingdao Vland Biotech Co Ltd from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.11 Billion ≈ $162.57 Million	-8.08%
2023-12-31	CN¥1.21 Billion ≈ $176.87 Million	+43.05%
2022-12-31	CN¥844.93 Million ≈ $123.64 Million	+57.59%
2021-12-31	CN¥536.18 Million ≈ $78.46 Million	+59.47%
2020-12-31	CN¥336.22 Million ≈ $49.20 Million	+35.03%
2019-12-31	CN¥248.99 Million ≈ $36.44 Million	-20.69%
2018-12-31	CN¥313.94 Million ≈ $45.94 Million	+7.88%
2017-12-31	CN¥291.02 Million ≈ $42.59 Million	+7.80%
2016-12-31	CN¥269.96 Million ≈ $39.50 Million	-10.69%
2015-12-31	CN¥302.27 Million ≈ $44.23 Million	-8.00%
2014-12-31	CN¥328.53 Million ≈ $48.07 Million	--

About Qingdao Vland Biotech Co Ltd

SHG:603739 China Biotechnology

Market Cap

$562.80 Million

CN¥3.85 Billion CNY

Market Cap Rank

#11951 Global

#3672 in China

Share Price

CN¥15.20

Change (1 day)

+1.00%

52-Week Range

CN¥12.76 - CN¥16.74

All Time High

CN¥58.91